About Lineagen
Lineagen is a company based in Salt Lake City (United States) founded in 2002 was acquired by Bionano Genomics in August 2020.. Lineagen has raised $66.93 million across 7 funding rounds from investors including Hatteras Funds, Petra Capital Partners and Health Quest Capital. The company has 40 employees as of December 31, 2022. Lineagen offers products and services including FirstStep Dx PLUS, NextStep Dx PLUS, OGM-Dx Postnatal Whole Genome SV, and OGM-Dx Prenatal Whole Genome SV. Lineagen operates in a competitive market with competitors including Invitae, Myriad Genetics, Genome Medical, Centogene and Fulgent Genetics, among others.
- Headquarter Salt Lake City, United States
- Employees 40 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lineagen Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$66.93 M (USD)
in 7 rounds
-
Latest Funding Round
$12.17 M (USD), Series C
Jan 26, 2015
-
Investors
Hatteras Funds
& 11 more
-
Employee Count
40
as on Dec 31, 2022
-
Acquired by
Bionano Genomics
(Aug 24, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lineagen
Lineagen offers a comprehensive portfolio of products and services, including FirstStep Dx PLUS, NextStep Dx PLUS, OGM-Dx Postnatal Whole Genome SV, and OGM-Dx Prenatal Whole Genome SV. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Diagnostic test for pediatric neurodevelopmental disorders using chromosomal microarray.
Service for whole exome sequencing to identify genetic variants.
Assessment of structural variants in postnatal genome testing.
Prenatal testing for genome structural variants.
Funding Insights of Lineagen
Lineagen has successfully raised a total of $66.93M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $12.17 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $12.2M
-
First Round
First Round
(22 Jun 2010)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2015 | Amount | Series C - Lineagen | Valuation | Health Quest Capital | |
| Nov, 2013 | Amount | Series C - Lineagen | Valuation |
investors |
|
| Nov, 2013 | Amount | Series B - Lineagen | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lineagen
Lineagen has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Hatteras Funds, Petra Capital Partners and Health Quest Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity fund.
|
Founded Year | Domain | Location | |
|
Investments are focused on tech and life sciences startups.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward life sciences and technology sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lineagen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lineagen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lineagen Comparisons
Competitors of Lineagen
Lineagen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Invitae, Myriad Genetics, Genome Medical, Centogene and Fulgent Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Genomic testing services are provided clinically and directly to consumers.
|
|
| domain | founded_year | HQ Location |
Provider of biochemical/genetic tests to detect mutations and rare diseases
|
|
| domain | founded_year | HQ Location |
Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer
|
|
| domain | founded_year | HQ Location |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lineagen
Frequently Asked Questions about Lineagen
When was Lineagen founded?
Lineagen was founded in 2002 and raised its 1st funding round 8 years after it was founded.
Where is Lineagen located?
Lineagen is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Is Lineagen a funded company?
Lineagen is a funded company, having raised a total of $66.93M across 7 funding rounds to date. The company's 1st funding round was a Series B of $16.11M, raised on Jun 22, 2010.
How many employees does Lineagen have?
As of Dec 31, 2022, the latest employee count at Lineagen is 40.
What does Lineagen do?
Lineagen was founded in 2002 and is based in Salt Lake City, United States. Diagnostic tests based on sequencing technology, along with consultative services, are offered to physicians evaluating children with autism or developmental delays. Support is extended to parents through these resources. Digital platforms including m-chat.org for online screening tools and OpenAutism.com for specialist information exchange are maintained in the healthcare sector focused on neurodevelopmental disorders.
Who are the top competitors of Lineagen?
Lineagen's top competitors include Fulgent Genetics, Centogene and Myriad Genetics.
What products or services does Lineagen offer?
Lineagen offers FirstStep Dx PLUS, NextStep Dx PLUS, OGM-Dx Postnatal Whole Genome SV, and OGM-Dx Prenatal Whole Genome SV.
Who are Lineagen's investors?
Lineagen has 12 investors. Key investors include Hatteras Funds, Petra Capital Partners, Health Quest Capital, Mountain Group Partners, and Sanderling Ventures.